CUP: E89J20000940006
(A19_POR-FESR-2014-2020_2021_FD131799) REAGENTI PER COVID PER LABORATORIO ANALISI
SUMMARY OF THE PROJECT
(A19_POR-FESR-2014-2020_2021_FD131799) REAGENTI PER COVID PER LABORATORIO ANALISI
Download project
Funding monitored
€ 3,460,231.35
of which cohesion funds
€ 3,460,231.35
| Given name | Amount |
|---|---|
| European Union | 1315426.66 |
| Revolving Fund | 920798.66 |
| Region | 394628.00 |
| Another public source | 829378.03 |
Payments monitored
€ 3,460,231.35
of which cohesion funds
€ 3,460,231.35
| Year | Amount | Cumulative amount | Percentage on public financing |
|---|---|---|---|
| 2020 | 1042645.55 | 1042645.55 | 30 |
| 2021 | 2075943.78 | 3118589.33 | 90 |
| 2022 | 341642.02 | 3460231.35 | 100 |
State of progress
Completed
Expected start: 06/07/2021
Effective start: 06/07/2021
Expected end: 31/12/2021
Effective end: 05/10/2021
Entities
- Planning body
- REGIONE PIEMONTE
- Implementing body
- REGIONE PIEMONTE
- Beneficiary
- AZIENDA OSPEDALIERO UNIVERSITARIA S LUIGI GONZAGA
- Executor
-
RELAB SRL
RANDOX LABORATORIES ITALIA
QUIDEL ITALY SRL
PIKDARE SPA
EUROSPITAL SPA
EPPENDORF
DIAGNOSTIC INT DISTRIBUTION SPA
BIOMEDICAL SERVICE SRL
BIOMED SRL
BECTON DICKINSON
Visualizzati i primi 10 soggetti di 13
Programming area
- European Regional Development Fund (ERDF)
- 2014-2020 EU Structural Funds
- Programme
- ROP ERDF PIEDMONT
- Axis
- RICERCA, SVILUPPO TECNOLOGICO E INNOVAZIONE
- Specific objective
- Promuovere gli investimenti necessari per il rafforzamento della capacità di risposta alla crisi nei servizi sanitari